Development of an Economic Model to Assess the Cost Effectiveness of Treatment Interventions for Chronic Obstructive Pulmonary Disease

Author： Spencer Michael

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.6, 2005-01, pp. : 619-637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease: A Review of the Evidence and Methodological Issues

By Mölken Maureen P.M.H. Rutten-van Goossens Lucas M.A.

PharmacoEconomics, Vol. 30, Iss. 4, 2012-04 ,pp. : 271-302

Adis International

Access to resources Recommend Favorite

A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease

By Mölken Maureen P.M.H. Rutten-van

PharmacoEconomics, Vol. 25, Iss. 8, 2007-01 ,pp. : 695-711

Adis International

Access to resources Recommend Favorite

Economic Burden of Chronic Obstructive Pulmonary Disease: Impact of New Treatment Options

By Friedman M.

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 245-254

Adis International

Access to resources Recommend Favorite

A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease

By Menn Petra Leidl Reiner Holle Rolf

PharmacoEconomics, Vol. 30, Iss. 9, 2012-09 ,pp. : 825-840

Adis International

Access to resources Recommend Favorite

Development of an Economic Model to Assess the Cost Effectiveness of Asthma Management Strategies

By Price M.J.

PharmacoEconomics, Vol. 20, Iss. 3, 2002-01 ,pp. : 183-194

Adis International

Access to resources Recommend Favorite